Skip to content
StockMarketAgent
Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/311960 stock hub

XKON/311960 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

XKON/311960is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
5.8B
Korea New Exchange
Market data

Live price

Current market quote for this ticker.

Current price
XKON/311960
In the news

Latest news · XKON/311960

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROICn/a
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All XKON/311960 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
78
Groups with data
6
Currency
KRW
Showing 78 of 78 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

13
MetricValue
Country
South Korea
Country code
KR
Exchange
Korea New Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
In Vitro and In Vivo Diagnostic Substances
Last refreshed
2026-05-10
Market cap
KRW 5.8B
Price
KRW 1,900
Price currency
KRW
Sic
2835
Symbol
xkon/311960
Website
https://interroid.com

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

2
MetricValue
Cagr1y
-50.99%
Cagr3y
-48.93%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

1
MetricValue
WACC
7.09

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-50.97%
200-day SMA
1,892
3Y total return
-86.69%
50-day SMA
1,735.6
50-day SMA vs 200-day SMA
50under200
All Time High
29,300
All Time High Change
-93.52%
All Time High Date
2022-11-30
All Time Low
756
All Time Low Change
151.32%
All Time Low Date
2025-03-06
ATR
293.9
Beta
0.52
Beta1y
0.94
Beta2y
-0.67
Ch YTD
11.9
High
1,999
High52
4,500
High52 Date
2025-05-16
High52ch
-57.78%
Low
1,697
Low52
1,105
Low52 Date
2026-03-11
Low52ch
71.95%
Ma50ch
9.47%
Price vs 200-day SMA
0.42%
RSI
49.53
RSI Monthly
31.77
RSI Weekly
49.9
Sharpe ratio
-0.33x
Sortino ratio
-0.4
Tr YTD
11.9
Tr1m
19.5%
Tr1w
-9.52%
Tr3m
-4.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

3
MetricValue
Float
1,383,907%
Shares Insiders
49.1%
Shares Out
3,062,664

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

24
MetricValue
Average Volume
191.6x
Ch1m
19.5
Ch1w
-9.52
Ch1y
-50.97
Ch3m
-4.81
Ch3y
-86.69
Ch6m
-9.52
Change
-4.81%
Change From Open
-4.81
Close
1,996
Days Gap
0
Dollar Volume
203,300
F Score
0
Is Primary Listing
1
Ma150
1,824
Ma150ch
4.17%
Ma20
1,947.6
Ma20ch
-2.44%
Open
1,996
Position In Range
67.22
Price Date
2026-05-08
Relative Volume
0.56x
Tr6m
-9.52%
Volume
107
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does XKON/311960 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/311960 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-51.0%
S&P 500 1Y: n/a
3Y total return
-86.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns XKON/311960?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+49.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

XKON/311960 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.5
Neutral momentum band
Price vs 200-day MA
+0.4%
50/200-day relationship not available
Beta (5Y)
0.52
Less volatile than the market
Sharpe ratio
-0.33
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About XKON/311960

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/311960 stock rating?

xkon/311960 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/311960 analysis?

The full report lives at /stocks/xkon/311960/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/311960?

The latest report frames xkon/311960 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/311960 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.